Literature DB >> 26649985

FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.

Hylton V Joffe1, Christina Chang, Catherine Sewell, Olivia Easley, Christine Nguyen, Somya Dunn, Kimberly Lehrfeld, LaiMing Lee, Myong-Jin Kim, Ashley F Slagle, Julie Beitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26649985     DOI： 10.1056/NEJMp1513686

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women.

Authors:  Vitaly A Kushnir; Sarah K Darmon; David H Barad; Andrea Weghofer; Norbert Gleicher
Journal:  Endocrine       Date:  2018-10-11       Impact factor: 3.633

Review 2.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

Review 3.  Sex Differences in the Treatment of Sexual Dysfunction.

Authors:  Veronica Harsh; Anita H Clayton
Journal:  Curr Psychiatry Rep       Date:  2018-03-14       Impact factor: 5.285

4.  Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients.

Authors:  Sheriza N Baksh; Walid F Gellad; G Caleb Alexander
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

5.  Accidental Flibanserin Ingestion in Children Causing Acute Respiratory and Central Nervous System Depression: What Health Care Professionals Need to Know.

Authors:  Marcea B Whitaker; Miriam M Chehab; Christina Y Chang; Lynda V McCulley; Catherine A Sewell
Journal:  Obstet Gynecol       Date:  2022-03-10       Impact factor: 7.623

6.  Flibanserin Approval: Facts or Feelings?

Authors:  James A Simon; Irwin Goldstein; Noel N Kim; Murray A Freedman; Sharon J Parish
Journal:  Sex Med       Date:  2016-06       Impact factor: 2.491

7.  Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.

Authors:  Susan G Kornstein; James A Simon; Stuart C Apfel; James Yuan; Krista A Barbour; Robert Kissling
Journal:  J Womens Health (Larchmt)       Date:  2017-08-17       Impact factor: 2.681

Review 8.  Evaluation and Management of Hypoactive Sexual Desire Disorder.

Authors:  Anita H Clayton; Sheryl A Kingsberg; Irwin Goldstein
Journal:  Sex Med       Date:  2018-03-06       Impact factor: 2.491

9.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

10.  Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.

Authors:  Gary G Kay; Thomas Hochadel; Eric Sicard; Karthi K Natarajan; Noel N Kim
Journal:  Hum Psychopharmacol       Date:  2017-05-31       Impact factor: 1.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.